Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain

Area of Science:

• Neuroscience
• Psychiatry
• Molecular Biology

Background:

• The D4 dopamine receptor is a potential target for novel antipsychotic drug development.
• Altered D4 dopamine receptor levels in schizophrenia are of significant interest, but difficult to quantify.
• Previous research lacked specific radioligands for accurate D4 receptor measurement.

Purpose of the Study:

• To investigate alterations in D4 dopamine receptor mRNA levels in the brain of individuals with schizophrenia.
• To compare D4 mRNA levels in the frontal cortex and caudate regions between schizophrenic patients and healthy controls.

Main Methods:

• Utilized ribonuclease protection assays on postmortem brain RNA from schizophrenics and controls.
• Employed 32P-labelled RNA probes for D4 dopamine receptor and glyceraldehyde-3-phosphate dehydrogenase (G3PDH).
• Quantified relative D4 mRNA levels using densitometry analysis of autoradiograms.

Main Results:

• A significant 3-fold increase in D4 mRNA levels was observed in the frontal cortex of schizophrenics compared to controls (P<0.011).
• No significant difference in D4 mRNA levels was found in the caudate region.
• Data indicates region-specific alterations in D4 dopamine receptor gene expression in schizophrenia.

Conclusions:

• Elevated D4 dopamine receptor mRNA in the frontal cortex suggests a role in schizophrenia.
• D4 receptors may be involved in mediating dopaminergic activity in the frontal cortex, potentially malfunctioning in schizophrenia.
• These findings support the D4 dopamine receptor as a target for antipsychotic drug development.